Literature DB >> 17431376

Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007.

.   

Abstract

Staphylococcus aureus infection has been reported infrequently as a cause of community-acquired pneumonia (CAP) and typically has been associated with influenza virus infection or influenza-like illness (ILI). During the 2003-04 influenza season, methicillin-resistant S. aureus (MRSA) gained attention as a cause of 15 cases of influenza-associated CAP. No formal surveillance has been conducted, and few additional cases of MRSA CAP were reported to CDC during the 2004-05 and 2005-06 influenza seasons. However, in January 2007, CDC received reports of 10 cases of severe MRSA CAP, including six deaths, among previously healthy children and adults in Louisiana and Georgia during December 2006-January 2007. These were the first reported cases of severe MRSA CAP during the 2006-07 influenza season in the two states, and 10 was a higher number than expected for the 2-month period. A case of severe MRSA CAP was defined as pneumonia requiring hospitalization or resulting in the death of a patient from whom a specimen (i.e., sterile site or sputum sample) yielded MRSA when collected <48 hours after hospitalization or arrival at an emergency department (ED). Association with influenza was determined by either a positive result on a laboratory test or a diagnosis of ILI. This report describes three of the MRSA CAP cases as examples and summarizes all 10 of the reported cases. These cases underscore the need for health-care providers to be vigilant, especially during the influenza season, for severe cases of CAP that might be caused by MRSA.

Entities:  

Mesh:

Year:  2007        PMID: 17431376

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  61 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

3.  Secondary bacterial pneumonia due to Staphylococcus aureus complicating 2009 influenza A (H1N1) viral infection.

Authors:  C Tsigrelis; M Mohammad; H S Fraimow; R P Dellinger; D Marchesani; A C Reboli
Journal:  Infection       Date:  2010-03-18       Impact factor: 3.553

4.  Natural and ion-exchanged illite clays reduce bacterial burden and inflammation in cutaneous meticillin-resistant Staphylococcus aureus infections in mice.

Authors:  Caitlin C Otto; Jacquelyn Kilbourne; Shelley E Haydel
Journal:  J Med Microbiol       Date:  2015-10-27       Impact factor: 2.472

5.  A model for surveillance of methicillin-resistant Staphylococcus aureus.

Authors:  Hannah Simons; Philip Alcabes
Journal:  Public Health Rep       Date:  2008 Jan-Feb       Impact factor: 2.792

Review 6.  Influenza.

Authors:  John H Beigel
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

7.  Rapidly fatal necrotizing pneumonia in a 12-year-old boy caused by co-infection with parainfluenza virus type 1 and Panton-Valentine leukocidin (PVL)-positive methicillin-sensitive Staphylococcus aureus.

Authors:  J J Wenzel; J Hentschel; W Silvis; W Permanetter; J Mattes; B Kochanowski; R Herterich; W Jilg; H J Linde
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

Review 8.  Recent changes in the management of community acquired pneumonia in adults.

Authors:  Hannah J Durrington; Charlotte Summers
Journal:  BMJ       Date:  2008-06-21

Review 9.  Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.

Authors:  Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia.

Authors:  Binh An Diep; Anna Afasizheva; Hoan N Le; Osamu Kajikawa; Gustavo Matute-Bello; Christine Tkaczyk; Bret Sellman; Cedric Badiou; Gerard Lina; Henry F Chambers
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.